Dysbiosis in the Gut Microbiome of Pembrolizumab‐Treated Non‐Small Lung Cancer Patients Compared to Healthy Controls Characterized Through Opportunistic SamplingHaris Charalambous, Άθως Αντωνιάδης, Paris Vogazianos et al.|Thoracic Cancer|2025Cited by 4